#lpa pathway

1 story

#cardiovascular #cholesterol #hedge funds #investor sentiment #ionis #lpa #lpa horizon #market reaction #novartis #pelacarsen #trial

Novartis and Ionis Cholesterol Drug Fails Trial
Novartis and Ionis' cholesterol drug failed to reduce heart attacks in late-stage trial.
Yahoo Finance · 1m